vpfreevideopoker| Kanghua Biotech: ACYW135 meningococcal polysaccharide vaccine raw solution workshop has not yet obtained production license

News summary

Kanghua Biotech: ACYW135 meningococcal polysaccharide vaccine raw solution workshop has not yet obtained production license. Securities Times e Company NewsvpfreevideopokerKanghua Biotech (300841) stated on the interactive platform on April 26 that the company's ACYW135 meningococcal polysaccharide vaccine raw solution workshop has not yet obtained a production license. The company isvpfreevideopoker...

Newsletter text

Kanghua Biotech: The ACYW135 meningococcal polysaccharide vaccine stock solution workshop has not yet obtained a production license. Securities Times Company News, Kanghua Biotech (300841) stated on the interactive platform on April 26 that the company's ACYW135 meningococcal polysaccharide vaccine stock solution workshop has not yet obtained a production license, and the company is promoting the acquisition of a production license for this workshop.